EMERGENCE
Setting the bases for synthetic biology in Europe
Synthetic biology has emerged as a very recent but highly promising approach to re-organizing the scientific biological endeavor by integrating central elements of engineering design. By applying the tool box of engineering disciplines such as electrical, mechanical, or chemical engineering and computer sciences, including the vigorous application of modeling techniques and organizing the development of novel biological systems along a hierarchical systems architecture with defined and standardized interfaces, synthetic biology aims at no less than revolutionizing the way we do bioengineering today. If successful, synthetic biology will transform bioengineering into a highly successful and sustainable life science industry.The objective of this coordination action (CA) EMERGENCE is to provide a communication and working platform for the emerging European synthetic biology community in order to strengthen the organizational and conceptual basis of the synthetic biology as a true engineering discipline in biological engineering.
Partner
Federal Institute of Technology (ETH Zurich), Sven Panke, Jörg Stelling, Frauke Greve
Consejo Superior de Investigaciones Scientificas (CSIC), Victor de Lorenzo
Spanish National Cancer Research Centre (CNIO), Alfonso Valencia
Helmholtz Zentrum für Infektionsforschung, (HZI), Vitor Martins dos Santos
Royal DSM, Luis Pasamontes
University College London (UCL), Nicolas Szita
Geneart AG, Ralf Wagner, Marcus Graf
Center for Genomic Regulation (CRG), Luis Serrano
University of Cambridge (UCAM), Jim Haseloff
Ecole Polytechnique (EP), Alfonso Jaramillo
Massachusetts Institute of Technology (MIT), Randy Rettberg
Sprecher
Vitor Martins dos Santos
Koordinator
ETH Zürich (CH)
Homepage
Geldgeber / Förderer
EU - Europäische Union